Oxford Cancer Biomarkers OCB


Personalising cancer medicines

Our pioneering biomarker technology predicts which cancer patients will respond favourably to existing and emerging cancer drugs, allowing treatment to be tailored to individual patients.

Assisting partner companies to achieve rapid market entry

We are looking to partner with leading care organisations and drug development companies.



Leave a comment

February 18, 2013 · 8:25 pm

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s